Malignant Melanoma of Head and Neck
| Primary Site | Histology |
|---|---|
| C003-C005, C008-C009, C019, C020-C024, C028-C029, C030-C031, C039, C040-C041, C048-C049, C050-C052, C058-C059, C060-C062, C068-C069, C090-C091, C098-C099, C100-C104, C108-C109, C110-C113, C118-C119, C129, C130-C132, C138-C139, C140, C142, C148, C300-C313, C318-C319, C320-C323, C328-C329 | 8720-8790 |
Notes
8720-8790 (C003-C005, C008-C069, C090-C148, C300-C329)
Note 1: Sources used in the development of this schema
- SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998) (https://seer.cancer.gov/archive/manuals/EOD10Dig.3rd.pdf)
- SEER Summary Staging Manual-2000: Codes and Coding Instructions (https://seer.cancer.gov/tools/ssm/ssm2000/)
- Collaborative Stage Data Collection System, version 02.05: https://cancerstaging.org/cstage/Pages/default.aspx
- Chapter 14 Mucosal Melanoma of the Head and Neck, in the AJCC Cancer Staging Manual, Eighth Edition (2017) published by Springer International Publishing. Used with permission of the American College of Surgeons, Chicago, Illinois.
Note 2: Mucosal melanomas
- Mucosal melanomas occur throughout the mucosa of
- Lip and oral cavity (C003-C005, C008-C069, C090-C148)
- Nasal cavity and middle ear (C300-C301)
- Accessory sinuses (C310-C319)
- Larynx (C320-C329).
- For a more detailed description of anatomy, refer to the appropriate Summary Stage 2018 chapter based on the location of the mucosal melanoma.
Data Items
| Name | Default Value | Used in Derivation | NAACCR Item | Required By | Metadata |
|---|---|---|---|---|---|
| Year of Diagnosis | <BLANK> | No |
NAACCR #390
dateOfDiagnosis |
None | |
| Primary Site | <BLANK> | Yes |
NAACCR #400
primarySite |
None | |
| Histology | <BLANK> | Yes |
NAACCR #522
histologicTypeIcdO3 |
None | |
| Behavior | <BLANK> | Yes |
NAACCR #523
behaviorCodeIcdO3 |
None | |
| Tumor Size Clinical | <BLANK> | No |
NAACCR #752
tumorSizeClinical |
None | |
| Tumor Size Pathological | <BLANK> | No |
NAACCR #754
tumorSizePathologic |
None | |
| Tumor Size Summary | 999 | No |
NAACCR #756
tumorSizeSummary |
None | |
| Regional Nodes Positive | 99 | No |
NAACCR #820
regionalNodesPositive |
None | |
| Regional Nodes Examined | 99 | No |
NAACCR #830
regionalNodesExamined |
None | |
| RX Summ Surgery/Radiation Sequence | <BLANK> | No |
NAACCR #1380
rxSummSurgRadSeq |
None | |
| RX Summ Systemic/Surgery Sequence | <BLANK> | No |
NAACCR #1639
rxSummSystemicSurSeq |
None | |
| Neoadjuvant Therapy | 9 | No |
NAACCR #1632
neoadjuvantTherapy |
None | |
| Neoadjuvant Therapy – Clinical Response | 9 | No |
NAACCR #1633
neoadjuvTherapyClinicalResponse |
None | |
| Neoadjuvant Therapy – Treatment Effect | 9 | No |
NAACCR #1634
neoadjuvTherapyTreatmentEffect |
None | |
| EOD Primary Tumor | 999 | Yes |
NAACCR #772
eodPrimaryTumor |
None | |
| EOD Regional Nodes | 999 | Yes |
NAACCR #774
eodRegionalNodes |
None | |
| EOD Mets | 00 | Yes |
NAACCR #776
eodMets |
None | |
| SS2018 | <BLANK> | No |
NAACCR #764
summaryStage2018 |
None | |
| Grade Clinical | 9 | Yes |
NAACCR #3843
gradeClinical |
All | SSDI |
| Grade Pathological | 9 | Yes |
NAACCR #3844
gradePathological |
All | SSDI |
| Grade Post Therapy Clin (yc) | <BLANK> | No |
NAACCR #1068
gradePostTherapyClin |
COC NPCR SEER |
SSDI |
| Grade Post Therapy Path (yp) | <BLANK> | No |
NAACCR #3845
gradePostTherapy |
CCCR/Canada COC NPCR SEER |
SSDI |
| Extranodal Exten H&N Clin | 8 | No |
NAACCR #3831
extranodalExtensionHeadNeckClin |
COC SEER (RC) |
SSDI |
| Extranodal Exten H&N Path | X.8 | No |
NAACCR #3832
extranodalExtensionHeadNeckPath |
CCCR/Canada COC SEER |
SSDI |
| LN Size | XX.8 | No |
NAACCR #3883
lnSize |
CCCR/Canada COC SEER |
SSDI |
| Lymph Nodes H&N Lev I-III | 8 | No |
NAACCR #3876
lnHeadAndNeckLevels1To3 |
COC SEER |
SSDI |
| Lymph Nodes H&N Lev IV-V | 8 | No |
NAACCR #3877
lnHeadAndNeckLevels4To5 |
COC SEER |
SSDI |
| Lymph Nodes H&N Lev VI-VII | 8 | No |
NAACCR #3878
lnHeadAndNeckLevels6To7 |
COC SEER |
SSDI |
| Lymph Nodes H&N Other | 8 | No |
NAACCR #3879
lnHeadAndNeckOther |
COC SEER |
SSDI |